Reunion Neuroscience Investor Relations Material
Latest events
Q3 2023
Reunion Neuroscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Reunion Neuroscience Inc
Access all reports
Reunion Neuroscience Inc. is a biotechnology company focused on developing innovative treatments for mental health conditions, with a particular emphasis on psychedelic-inspired therapies. The company’s lead programs are aimed at addressing major depressive disorder and other mental health challenges using novel compounds derived from psychedelics. Reunion Neuroscience seeks to advance clinical research and leverage its proprietary technologies to offer new treatment options for patients where traditional therapies may have limited effectiveness. The company is headquartered in Toronto, Canada, and its shares are listed on the Nasdaq.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
REUN
Country
🇺🇸 United States